[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Questions and Answers on Current Good
Manufacturing Practices (cGMP) for Drugs

As part of the cGMP initiative announced in August of 2002, and to help FDA be more transparent with cGMP policy, we have developed this question and answer resource on Current Good Manufacturing Practices. We intend to use this format to provide timely answers to questions about the meaning and application of cGMPs for human, animal, and biological drugs, and to share these widely. These questions and answers generally clarify statements of existing requirements or policy, and as such, are considered Level 2 guidance. This resource is being co-sponsored by CDER, CVM, CBER, and ORA.

Guidance documents represent the Agency's current thinking on a particular subject (21 CFR 10.115). They do not create or confer any rights for or on any person and do not operate to bind FDA or the public. You can use an alternative approach if such approach satisfies the requirements of the application statute, regulations, or both. For more information about a specific guidance document, please contact the originating office.

Back to Top     Back to Guidances

Date created: August 4, 2004, updated October 25, 2007

horizonal rule